Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03336333
Title A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL (SEQUOIA)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene
Indications

chronic lymphocytic leukemia

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Venetoclax + Zanubrutinib

Zanubrutinib

Bendamustine + Rituximab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL | AUT


No variant requirements are available.